RESTARRT ITN039ST: ATG, Rituximab, Tacrolimus, MMF, Sirolimus and IS Withdrawal in Renal Transplantation
收藏官方服务：
资源简介：
This single-arm clinical trial, conducted by the Immune Tolerance Network, evaluated whether induction with antithymocyte globulin (ATG) and rituximab, followed by maintenance immunosuppression and staged withdrawal, could enable sustained immunosuppression-free survival in adult recipients of living-donor renal transplants.
提供机构：
ImmPort创建时间：
2025-09-25
